LIEN vs SRPT · P/E 6.5, $223.4M cap vs rev $1.90B
Chicago Atlantic BDC, Inc. (LIEN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Chicago Atlantic BDC, Inc. (LIEN) is a asset management company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
LIEN does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
LIEN currently screens at market cap $223.4M and trailing P/E 6.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the LIEN and SRPT stock pages for the full models.
Not investment advice.